$KRRO

Dolan Oliver sold $69 of KRRO

Dolan Oliver (Senior Vice President, Finance) sold 5 shares of Korro Bio, Inc. (KRRO) at $13.72 on 2026-09-11 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Dolan Oliver
Published Sep 14, 2026, 8:05 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 14, 2026, 8:12 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$KRRO
Neutral
medium confidence
Mentioned
$KRRO
Relevance
2/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$KRRONeutralLow
01

Why it matters

The transaction is a routine 10b5‑1 sale with negligible market impact.

02

Market read

Small insider sale; unlikely to affect price or trading decisions.

03

What to watch

Potential upcoming corporate events or financing that may affect future insider activity.

Relevance 2/10Novelty 3/10Timing: filed Sep 14 2026

Background

Form 4 filing discloses insider transactions required by SEC regulations.

Company-level read

Ticker impact

$KRRONeutralMedium confidence
Context

Senior Vice President of Finance sold 5 shares for $68.58 via a pre‑arranged 10b5‑1 plan on Sep 11, 2026.

Expected impact

minor downward pressure

Evidence & confidence

Sale size is trivial relative to holdings; insider is using a 10b5‑1 plan, suggesting no urgent need to liquidate.

Market effects

No significant impact on the biotech sector; typical insider sale.

Limited to U.S. investors tracking KRRO.

Minimal global relevance.

Counterpoint

The sale could be a routine portfolio rebalancing and not a negative signal.

Key entities

  • Korro Bio, Inc.

    Biotech firm listed on Nasdaq under KRRO.

  • Dolan Oliver

    Senior Vice President, Finance at Korro Bio.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$KRROMed

Korro Bio, Inc. (KRRO): Results of Operations and Financial Condition

Korro Bio, Inc. (KRRO) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Korro Reports Second Quarter 2026 Financial Results and Provides Corporate Update — KRRO-121, a potential first-in-class transformational treatment for hyperammonemia, remains on track to commence first-in-human clinical trial in second half of 2026 — Received Orphan

$DELLLow

Silver Lake Partners IV, L.P. (Durban Egon) sold $44.2M of DELL (indirect holdings)

Silver Lake Partners IV, L.P. sold 79,072 indirectly-held shares of Dell Technologies Inc. (DELL) at an average of $558.74 ($547.73–$567.45, $44.18M total) across 20 trades on 2026-09-11. Filed jointly with Silver Lake Technology Associates IV, L.P. (Director), SLTA IV (GP), L.L.C. (Director), Silver Lake Group, L.L.C. (Director) and Durban Egon (Director).

$DELLLow

Silver Lake Partners V DE (AIV), L.P. (Durban Egon) sold $23.2M of DELL (indirect holdings)

Silver Lake Partners V DE (AIV), L.P. sold 41,434 indirectly-held shares of Dell Technologies Inc. (DELL) at an average of $558.74 ($547.73–$567.45, $23.15M total) across 20 trades on 2026-09-11. Filed jointly with Silver Lake Technology Associates V, L.P. (Director), SLTA V (GP), L.L.C. (Director), Silver Lake Group, L.L.C. (Director) and Durban Egon (Director).

$AMALLow

Western States Regional Joint Board, Workers United sold $22.1M of AMAL

Western States Regional Joint Board, Workers United sold 462,412 shares of Amalgamated Financial Corp. (AMAL) at an average of $47.86 ($47.69–$47.98, $22.13M total) across 5 trades over 2026-09-11 to 2026-09-14. Filed jointly with Workers United Canada Council (10% owner), Southern Region Workers United/SEIU (10% owner) and Southwest Regional Joint Board, Workers United (10% owner).